Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Public Health

    Attributes and Predictors of Long-COVID

    By Global Biodefense StaffOctober 24, 2020
    Photo by TamWai / Unsplash
    Share
    Facebook LinkedIn Reddit Email

    Long-COVID is characterized by symptoms of fatigue, headache, dyspnoea and anosmia. At the population level, it is critical to quantify the burden of Long-COVID to better assess its impact on the healthcare system and appropriately distribute resources.

    A new study led by researchers from King’s College London suggests Long-COVID affects around 10% of 18-to 49-year-olds following infection with SARS-CoV-2. The study found the syndrome was more likely with increasing age, body mass index (BMI) and female sex.

    The scientists analyzed data from 4182 incident cases of self-logged symptoms in the COVID Symptom Study app.

    The researchers also found that experiencing more than five symptoms during the first week of illness was associated with Long-COVID.

    The method underscored in the study could help determine at-risk groups and could be used to target early intervention trials of treatment and and clinical service developments to support rehabilitation to alleviate Long-COVID.

    This paper is a medRxiv pre-print still undergoing peer-review

    Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. October 21, 2020. https://doi.org/10.1101/2020.10.19.20214494

    COVID-19 Editor Pick Epidemiology Medicine-Health SARS-CoV-2
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleHydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit
    Next Article Keep Focus on Emerging Infections, Disease X: Analysts

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy